Gerber Products Company logo, baby food and baby product brand, graphic element on white via Associated Press
Contamination concerns have forced Gerber to pull some of its baby formula from store shelves.
Gerber parent company Perrigo issued a voluntary recall of Gerber's Good Start SoothePro Infant Formula "out of an abundance of caution" regarding a link to possible Cronobacter sakazakii contamination.
The impacted products were manufactured in Eau Claire, Wisconsin between January 2 and January 18.
"Importantly, no distributed product has tested positive for the presence of this bacteria, no adverse events have been reported and no other products manufactured at this facility or any other of Perrigo's facilities are affected by this recall," the company said in a statement.
Cronobacter sakazakii is a bacteria that is relatively common and typically does not impact most people, but when newborns and infants with compromised immune systems are exposed, it can potentially cause sepsis and meningitis, according to the Centers for Disease Control and Prevention.
"Every batch of infant formula is tested to make certain it meets stringent nutritional, safety, quality and regulatory requirements," Perrigo Company stated.
The recall comes just a month after an Enfamil baby formula recall due to concerns over the same kind of contamination.
Skift Editor-In-Chief Sarah Kopit discusses how summer travel plans remain uncertain for most as many international travelers are leery to travel abroad. Watch!
Seth Schachner, Managing Director at Strat Americas, on Hollywood's latest blockbusters utilizing content creation. Plus, the future of YouTube and TikTok.
Ashley Gold, Axios' Tech/Policy reporter, discusses what the future of Google and search engines will look like after the tech giant faces an antitrust trial.
Seth Goldstein, Equity Strategist at Morningstar, breaks down Tesla's earnings report, talks Musk's future with the company and how stocks have responded.
Senior Health Correspondent for TIME, Alice Park, gives us a deeper look into how Eli Lilly's new pill orforglipron may change the healthcare industry.
Archer Aviation CEO Adam Goldstein talks about the advancements in electric air taxis and how his company is changing the future of air transportation. Watch!